About Us
Our Technology
Our Focus
Pipeline
More
October 16, 2024
Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders
July 28, 2024
Sunbird Bio Presents Latest Data Reinforcing Significance of Blood-Based Tau Biomarkers in the Accurate Diagnosis of Alzheimer’s Disease
July 11, 2024
Sunbird Bio to Present Data from Study Evaluating Tau Blood-Based Biomarkers at the Alzheimer’s Association International Conference® 2024 (AAIC®)